Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05323045
Title A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Byondis B.V.
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | GBR | BEL


No variant requirements are available.